Pancreatic Cancer
Showing NaN - NaN of 73
Pancreatic Cancer Trial in New Haven, New Brunswick, Nashville (anetumab ravtansine)
Completed
- Pancreatic Cancer
- anetumab ravtansine
-
New Haven, Connecticut
- +2 more
Oct 11, 2021
Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))
Completed
- Gastric Adenocarcinoma
- +15 more
- Sacituzumab Govitecan-hziy (SG)
-
Aurora, Colorado
- +11 more
Aug 10, 2021
Pancreatic Cancer Trial in United States (CS-1008 (humanized anti-DR5 antibody), gemcitabine)
Completed
- Pancreatic Cancer
- CS-1008 (humanized anti-DR5 antibody)
- gemcitabine
-
Birmingham, Alabama
- +11 more
Mar 11, 2021
Pancreatic Cancer Trial in Worldwide (Pegilodecakin, FOLFOX)
Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in United States (OMP-54F28, Nab-Paclitaxel and Gemcitabine)
Completed
- Pancreatic Cancer
- Stage IV Pancreatic Cancer
- OMP-54F28, Nab-Paclitaxel and Gemcitabine
-
Los Angeles, California
- +4 more
Sep 7, 2020
Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in United States (Vantictumab, Nab-Paclitaxel, Gemcitabine)
Completed
- Pancreatic Cancer
- Stage IV Pancreatic Cancer
- Vantictumab
- +2 more
-
Los Angeles, California
- +4 more
Sep 7, 2020
Pancreatic Cancer, NSCLC, Esophagogastric Cancer Trial in United States (Andecaliximab, Gemcitabine, Nab-paclitaxel)
Completed
- Pancreatic Cancer
- +4 more
- Andecaliximab
- +10 more
-
Birmingham, Alabama
- +17 more
May 20, 2020
Breast Cancer, Lung Cancer, Melanoma Trial in Nashville (1-methyl-D-tryptophan)
Terminated
- Breast Cancer
- +4 more
-
Nashville, TennesseeVanderbilt University
May 26, 2020
Pancreatic Cancer Trial in Worldwide (erlotinib HCl, gemcitabine HCl)
Completed
- Pancreatic Cancer
- erlotinib hydrochloride
- gemcitabine hydrochloride
-
Tucson, Arizona
- +172 more
Mar 31, 2020
Pancreatic Cancer Trial in Nashville (Romidepsin, Gemcitabine)
Completed
- Pancreatic Cancer
-
Nashville, TennesseeSarah Cannon Research Institute
Oct 16, 2019
Pancreatic Cancer, Colorectal Cancer, Rectal Cancer Trial in Nashville (TGR-1202, nab-paclitaxel + gemcitabine, Oxaliplatin +
Completed
- Pancreatic Cancer
- +5 more
- TGR-1202
- +3 more
-
Nashville, TennesseeTG Therapeutics Trial Site
Oct 1, 2019
Pancreatic Cancer Trial in Worldwide (Ruxolitinib, Placebo, Capecitabine)
NSCLC, Breast Cancer, Pancreatic Cancer Trial in United States (Ibrutinib, Durvalumab)
Completed
- Non-Small Cell Lung Cancer
- +2 more
-
Birmingham, Alabama
- +16 more
Dec 7, 2018
Pancreatic Cancer Trial in Worldwide (Ruxolitinib, Placebo, Capecitabine)
Solid Tumors, Pancreatic Cancer Trial in United States (ruxolitinib, gemcitabine, nab-paclitaxel)
Terminated
- Solid Tumors
- Pancreatic Cancer
- ruxolitinib
- +3 more
-
Birmingham, Alabama
- +4 more
Jan 15, 2018
Pancreatic Cancer Trial in Worldwide (Tarceva (erlotinib HCl, OSI-774))
Completed
- Pancreatic Cancer
- Tarceva (erlotinib HCl, OSI-774)
-
Tucson, Arizona
- +139 more
Jan 8, 2018
Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer Trial in Nashville (erlotinib HCl, gemcitabine HCl, oxaliplatin)
Completed
- Extrahepatic Bile Duct Cancer
- +5 more
- erlotinib hydrochloride
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jun 29, 2017
Pancreatic Cancer Trial in United States (OGX-427, Placebo)
Pancreatic Cancer Trial in United States (biological, drug, radiation)
Completed
- Pancreatic Cancer
- interferon-alfa-2b
- +3 more
-
Gainesville, Florida
- +13 more
Dec 5, 2016